Latest Breaking News On - Aptamer sciences inc - Page 4 : comparemela.com

Share this article Share this article ResearchAndMarkets.com s offering. Report Highlights The Parkinson s Disease (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Parkinson s Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities/Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 11, 48, 62, 4, 224, 97 and 9 respectively. Similarly, the Universities portfolio in Phase III, Phase II, Phase I, Preclinical and Discovery stages comprises 1, 1, 1, 52 and 19 molecules, respectively. The Parkinson s Disease (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter-strategies to gain competitive adva

Chongqing
China
Dublin
Ireland
Laura-wood
Cavogene-lifesciences
Corium-inc
Addex-therapeutics-ltd
Cerecor-inc
Biogen-inc
Cerevel-therapeutics
Companies-in-pre